Page 73 - Read Online

Page 20 of 25 Torres et al. J Cancer Metastasis Treat 2018;4:4 I http://dx.doi.org/10.20517/2394-4722.2017.49

108. Matsumoto Y, Miwa S, Zhang Y, Hiroshima Y, Yano S, Uehara F, Yamamoto M, Toneri M, Bouvet M, Matsubara H, Hoffman RM, Zhao
M. Efficacy of tumor-targetingsalmonella typhimuriumA1-R on nude mouse models of metastatic and disseminated human ovarian
cancer. J Cell Biochem 2014;115:1996-2003.
109. Zoaby N, Shainsky-Roitman J, Badarneh S, Abumanhal H, Leshansky A, Yaron S, Schroeder A. Autonomous bacterial nanoswimmers
target cancer. J Control Release 2017;257:68-75.
110. Toso J. Phase I study of the intravenous administration of attenuated salmonella typhimurium to patients with metastatic melanoma. J
Clin Oncol 2002;20:142-52.
111. Zhang Y, Miwa S, Zhang N, Hoffman R, Zhao M. Tumor-targeting Salmonella typhimurium A1-R arrests growth of breast-cancer brain
metastasis. Oncotarget 2014;6:2615-22.
112. Alimoradi H, Matikonda SS, Gamble AB, Giles GI, Greish K. Hypoxia responsive drug delivery systems in tumor therapy. Curr Pharm
Des 2016;22:2808-20.
113. Loeffler M, Le’Negrate G, Krajewska M, Reed J. Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor
growth. Proc Natl Acad Sci U S A 2007;104:12879-83.
114. Loeffler M, Le’Negrate G, Krajewska M, Reed J. IL-18-producing Salmonella inhibit tumor growth. Cancer Gene Ther 2008;15:787-
94.
115. Loeffler M, Le’Negrate G, Krajewska M, Reed J. Inhibition of tumor growth using salmonella expressing fas ligand. J Natl Cancer Inst
2008;100:1113-6.
116. Ganai S, Arenas R, Forbes N. Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in
mice. Br J Cancer 2009;101:1683-91.
117. Lee CH, Wu C, Shiau A. Endostatin gene therapy delivered bySalmonella choleraesuis in murine tumor models. J Gene Med
2004;6:1382-93.
118. Lee CH, Wu C, Shiau A. Salmonella choleraesuis as an anticancer agent in a syngeneic model of orthotopic hepatocellular carcinoma.
Int J Cancer 2008;122:930-5.
119. Zhang L, Gao L, Zhao L, Guo B, Ji K, Tian Y, Wang J, Yu H, Hu J, Kalvakolanu DV, Kopecko DJ, Zhao X, Xu DQ. Intratumoral
delivery and suppression of prostate tumor growth by attenuated salmonella enterica serovar typhimurium carrying plasmid-based small
interfering RNAs. Cancer Res 2007;67:5859-64.
120. Niethammer AG, Xiang R, Becker J, Wodrich H, Pertl U, Karsten G, Eliceiri BP, Reisfeld RA. A DNA vaccine against VEGF receptor 2
prevents effective angiogenesis and inhibits tumor growth. Nat Med 2002;8:1369-75.
121. Fensterle J, Bergmann B, Yone C, Hotz C, Meyer S, Spreng S, Goebel W, Rapp UR, Gentschevl. Cancer immunotherapy based on
recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B.
Cancer Gene Ther 2007;15:85-93.
122. Lemmon MJ, van Zijl P, Fox ME, Mauchline ML, Giaccia AJ, Minton NP, Brown JM. Anaerobic bacteria as a gene delivery system that
is controlled by the tumor microenvironment. Gene Ther 1997;4:791-6.
123. Fox ME, Lemmon MJ, Mauchline ML, Davis TO, Giaccia AJ, Minton NP, Brown JM. Anaerobic bacteria as a delivery system for
cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia. Gene Ther 1996;3:173-8.
124. Zhang YL, Lü R, Chang ZS, Zhang WQ, Wang QB, Ding SY, Zhao W. Clostridium sporogenes delivers interleukin-12 to hypoxic
tumours, producing antitumour activity without significant toxicity. Lett Appl Microbiol 2014;59:580-6.
125. Groot A, Mengesha A, Wall E, Diest P, Theys J, Vooijs M. Functional antibodies produced by oncolytic clostridia. Biochem Biophys Res
Commun 2007;364:985-9.
126. Gunn GR, Zubair A, Peters C, Pan ZK, Wu TC, Paterson Y. Two listeria monocytogenes vaccine vectors that express different molecular
forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to
induce regression of established tumors immortalized by HPV-16. J Immunol 2001;167:6471-9.
127. Shahabi V, Seavey M, Maciag P, Rivera S, Wallecha A. Development of a live and highly attenuated Listeria monocytogenes-based
vaccine for the treatment of Her2/neu-overexpressing cancers in human. Cancer Gene Ther 2010;18:53-62.
128. Kim S, Castro F, Gonzalez D, Maciag P, Paterson Y, Gravekamp C. Mage-b vaccine delivered by recombinant Listeria monocytogenes
is highly effective against breast cancer metastases. B J Cancer 2008;99:741-9.
129. Maciag PC, Seavey MM, Pan ZK, Ferrone S, Paterson Y. Cancer immunotherapy targeting the high molecular weight melanoma-
associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature. Cancer Res
2008;68:8066-75.
130. Zu C, Wang J. Tumor-colonizing bacteria: a potential tumor targeting therapy. Crit Rev Microbiol 2013;40:225-35.
131. Quispe-Tintaya W, Chandra D, Jahangir A, Harris M, Casadevall A, Dadachova E, Gravekamp C. Nontoxic radioactive Listeriaat is a
highly effective therapy against metastatic pancreatic cancer. Proc Natl Acad Sci U S A 2013;110:8668-73.
132. Hosseinidoust Z, Mostaghaci B, Yasa O, Park B, Singh A, Sitti M. Bioengineered and biohybrid bacteria-based systems for drug
delivery. Adv Drug Deliv Rev 2016;106:27-44.
133. Fu W, Chu L, Han X, Liu X, Ren D. Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-
related gene vector delivered by orally attenuated Salmonella enterica Serovar Typhimurium in murine tumor models. J Gene Med
2008;10:690-701.
134. Cicchelero L, Denies S, Devriendt B, de Rooster H, Sanders N. Can dendritic cells improve whole cancer cell vaccines based on
immunogenically killed cancer cells? Onco Immunology 2015;4:e1048413.